Hamid Sayar
Indiana University Health(US)Indiana Cancer Consortium(US)Indiana University – Purdue University Indianapolis(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Histone Deacetylase Inhibitors Research, Multiple Myeloma Research and Treatments, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Where West Meets East: The Complex mtDNA Landscape of the Southwest and Central Asian Corridor(2004)422 cited
- → Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission(2020)409 cited
- → Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study(2015)155 cited
- → The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission(2019)97 cited
- → Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study(2019)86 cited
- → Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)